Johnson & Johnson balance sheet

At the end of fiscal 2025, Johnson & Johnson had total assets of $199.21bn, total liabilities of $117.67bn and shareholders' equity of $81.54bn. It held $19.71bn in cash against $49.93bn of debt: net debt of $30.22bn.

Balance sheet

US$ billions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Johnson & Johnson: balance sheet, annual
Fiscal year	2009Jan 2010	2010Jan 2011	2011Jan 2012	2012Dec 2012	2013Dec 2013	2014Dec 2014	2015Jan 2016	2016Jan 2017	2017Dec 2017	2018Dec 2018	2019Dec 2019	2020Jan 2021	2021Jan 2022	2022Jan 2023	2023Dec 2023	2024Dec 2024	2025Dec 2025	LTMSept 2026
Cash and equivalents	15.8	19.4	24.5	14.9	20.9	14.5	13.7	19.0	17.8	18.1	17.3	14.0	14.5	12.9	21.9	24.1	19.7	16.9
Receivables	9.6	9.8	10.6	11.3	11.7	11.0	10.7	11.7	13.5	14.1	14.5	13.6	15.3	14.0	14.9	14.8	17.2	19.0
Inventory	5.2	5.4	6.3	7.5	7.9	8.2	8.1	8.1	8.8	8.6	9.0	9.3	10.4	10.3	11.2	12.4	14.2	15.4
Total current assets	39.5	47.3	54.3	46.1	56.4	55.7	60.2	65.0	43.1	46.0	45.3	51.2	61.0	55.3	53.5	55.9	55.6	56.4
Goodwill	14.9	15.3	16.1	22.4	22.8	21.8	21.6	22.8	31.9	30.5	33.6	36.4	25.4	36.0	36.6	44.2	48.8	48.5
Total assets	94.7	102.9	113.6	121.3	132.7	130.4	133.4	141.2	157.3	153.0	157.7	174.9	182.0	187.4	167.6	180.1	199.2	197.4
Accounts payable	5.5	5.6	5.7	5.8	6.3	7.6	6.7	6.9	7.3	7.5	8.5	9.5	11.1	9.9	9.6	10.3	12.0	9.3
Total current liabilities	21.7	23.1	22.8	24.3	25.7	25.0	27.7	26.3	30.5	31.2	36.0	42.5	45.2	55.8	46.3	50.3	54.1	55.5
Short-term debt	0.0	7.6	6.7	4.7	4.9	3.6	7.0	4.7	3.9	2.8	1.2	2.6	3.8	12.8	3.5	6.0	8.5	8.9
Long-term debt	8.2	9.2	13.0	11.5	13.3	15.1	12.9	22.4	30.7	27.7	26.5	32.6	30.0	26.9	25.9	30.7	39.4	35.8
Total debt	14.6	16.8	19.7	16.2	18.2	18.8	19.9	28.8	36.1	33.1	27.7	37.1	35.9	41.2	30.8	38.4	49.9	44.7
Total liabilities	44.1	46.3	56.6	56.5	58.6	60.6	62.3	70.8	97.1	93.2	98.3	111.6	108.0	110.6	98.8	108.6	117.7	115.9
Shareholders' equity	50.6	56.6	57.1	64.8	74.1	69.8	71.2	70.4	60.2	59.8	59.5	63.3	74.0	76.8	68.8	71.5	81.5	81.5
Net debt (negative = net cash)	−1.2	−2.6	−4.9	1.3	−2.7	4.2	6.1	9.9	18.3	15.0	10.4	23.1	21.4	28.3	8.9	14.3	30.2	27.7

US$ billions unless shown otherwise. Fiscal quarters.

Johnson & Johnson: balance sheet, quarterly
Quarter	2024 Q4Dec 2024	2025 Q1Mar 2025	2025 Q2Jun 2025	2025 Q3Sept 2025	2025 Q4Dec 2025	2026 Q1Mar 2026	2026 Q2Jun 2026	2026 Q3Sept 2026
Receivables	14.8	16.0	17.8	17.6	17.2	17.7	19.0	19.0
Inventory	12.4	12.7	13.4	14.1	14.2	14.6	15.1	15.4
Total current assets	55.9	71.6	54.5	54.6	55.6	59.2	59.8	56.4
Goodwill	44.2	44.5	48.1	48.0	48.8	48.6	48.5	48.5
Total assets	180.1	193.7	193.4	192.8	199.2	200.9	201.1	197.4
Accounts payable	10.3	9.5	9.5	9.6	12.0	10.5	9.2	9.3
Total current liabilities	50.3	56.9	54.2	50.9	54.1	57.7	54.9	55.5
Short-term debt	6.0	13.9	11.5	6.4	8.5	17.5	11.7	8.9
Long-term debt	30.7	38.4	39.2	39.4	39.4	37.5	37.3	35.8
Total debt	36.7	52.3	50.8	45.8	47.9	55.0	49.0	44.7
Total liabilities	108.6	115.6	114.9	113.5	117.7	119.7	116.1	115.9
Shareholders' equity	71.5	78.1	78.5	79.3	81.5	81.2	85.0	81.5

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: JNJ vs LLY JNJ vs MRK JNJ vs PFE

More: Pharmaceuticals stocks compared, Health Care sector, rankings of US companies

Figures from Johnson & Johnson's SEC filings (10-K and 10-Q), retrieved October 23, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Johnson & Johnson.